|
|
Volumn 28, Issue 5, 2014, Pages 1131-
|
|
What does MRD in leukemia really mean?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE INHIBITOR;
ACUTE GRANULOCYTIC LEUKEMIA;
BLOOD CELL;
BONE MARROW CELL;
CHRONIC MYELOID LEUKEMIA;
CYTOGENETICS;
DRUG EFFICACY;
FLUORESCENCE ACTIVATED CELL SORTER;
FUSION GENE;
HEMATOLOGIST;
HUMAN;
LETTER;
LEUKEMIA CELL;
METAPHASE CHROMOSOME;
MICROSCOPY;
MINIMAL RESIDUAL DISEASE;
PHENOTYPE;
PRIORITY JOURNAL;
REMISSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TREATMENT OUTCOME;
CELL SEPARATION;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MONITORING, PHYSIOLOGIC;
NEOPLASM, RESIDUAL;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
|
EID: 84899914304
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/leu.2013.318 Document Type: Letter |
|
Times cited : (30)
|
|
References (0)
|
